Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDegLira vs insulin degludec in Chinese adults with type 2 diabetes
CTR20160909Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- May 2017
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of insulin degludec + liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started May 2017; status: completed.
02
Drugs
insulin degludec + liraglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20160909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160909.